Clinical trial
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
NCT03825939 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- April 21, 2015
- Completion date
- September 6, 2016
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood loss